Viewing StudyNCT00060346



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00060346
Status: TERMINATED
Last Update Posted: 2023-06-29
First Post: 2003-05-06

Brief Title: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstroms Macroglobulinemia
Sponsor: Eastern Cooperative Oncology Group
Organization: Eastern Cooperative Oncology Group

Organization Data

Organization: Eastern Cooperative Oncology Group
Class: NETWORK
Study ID: CDR0000301634
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Eastern Cooperative Oncology Group
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH